Get started
Author

Imane CHAIB-OUKADOUR

Observed names: Chaib Oukadour, Imane, I. Chaib, Imane Chaib, Imane Chaib Oukadour, Imane Chaïb-Oukadour, Imane Chaïb‐Oukadour, Imane Chaı̈b-Oukadour
Observed institutions: University of Messina, Tongji University, University of Verona, West Virginia University, Universitat Autònoma de Barcelona, Nanjing University of Chinese Medicine, Royal Marsden NHS Foundation Trust, Memorial Sloan Kettering Cancer Center, University of Southern Denmark, Odense University Hospital, Ospedale "Santa Maria delle Croci" di Ravenna, Azienda Ospedaliera Universitaria Integrata Verona, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Hospital Universitario Puerta de Hierro Majadahonda, Institut Català d'Oncologia, Jiangsu Provincial Academy of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, Hospital Clínic de Barcelona, Centre Hospitalier Universitaire de Limoges, Royal Marsden Hospital, Instituto Oncológico de Córdoba, Hospital Universitario de La Princesa, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hospital de Cruces, China Academy of Chinese Medical Sciences, Institut Químic de Sarrià, Hospital Universitari Germans Trias i Pujol, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, UCSF Helen Diller Family Comprehensive Cancer Center, Instituto Nazionale Tumori Regina Elena, West Virginia Clinical and Translational Science Institute, Universitat Ramon Llull, European Institute of Oncology, Gdańsk Medical University, Nanjing University
OpenAlex ID: A5036738804
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
2017 · Imane Chaib, Niki Karachaliou, et al. · JNCI Journal of the National Cancer Institute · 210
PDF
BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer
2007 · Rafael Rosell, Marcin Skrzypski, et al. · PLoS ONE · 210
PDF
Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
2009 · Rafael Rosell, Laia Perez-Roca, et al. · PLoS ONE · 161
PDF
Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung
2008 · Marcin Skrzypski, Ewa Jassem, et al. · Clinical Cancer Research · 106
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
2020 · Mariacarmela Santarpia, Andrés Aguilar, et al. · Cancers · 101
PDF
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis
2018 · Niki Karachaliou, Imane Chaib, et al. · EBioMedicine · 81
PDF
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
2015 · Niki Karachaliou, Jordi Codony-Servat, et al. · Scientific Reports · 64
PDF
C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons
2003 · Carles GIL, Imane CHAIB-OUKADOUR, et al. · Biochemical Journal · 62
PDF
XPG mRNA Expression Levels Modulate Prognosis in Resected Non–Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression
2009 · Roberta Bartolucci, Jia Wei, et al. · Clinical Lung Cancer · 60
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)
2017 · Carles Codony-Servat, Jordi Codony-Servat, et al. · Oncotarget · 50
PDF
The C‐terminal domain of the heavy chain of tetanus toxin rescues cerebellar granule neurones from apoptotic death: involvement of phosphatidylinositol 3‐kinase and mitogen‐activated protein kinase pathways
2004 · Imane Chaïb‐Oukadour, Carles Gil, et al. · Journal of Neurochemistry · 47
PDF
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
2018 · Niki Karachaliou, Andres Felipe Cardona, et al. · EBioMedicine · 44
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer
2021 · Xueting Cai, Jing Miao, et al. · Pharmacological Research · 41
Activation of signal transduction pathways involving trkA, PLCγ‐1, PKC isoforms and ERK‐1/2 by tetanus toxin
2000 · Carles Gil, Imane Chaı̈b-Oukadour, et al. · FEBS Letters · 37
PDF
Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
2019 · Masaoki Ito, Carles Codony-Servat, et al. · Cell Communication and Signaling · 35
PDF
HC fragment (C-terminal portion of the heavy chain) of tetanus toxin activates protein kinase C isoforms and phosphoproteins involved in signal transduction
2001 · Carles GIL, Imane CHAIB-OUKADOUR, et al. · Biochemical Journal · 35
PDF
Tetanus toxin HC fragment reduces neuronal MPP+ toxicity
2009 · Imane Chaïb-Oukadour, Carles Gil, et al. · Molecular and Cellular Neuroscience · 34
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies
2014 · T. Moran, J. Wei, et al. · Annals of Oncology · 32
Melanoma: oncogenic drivers and the immune system.
2015 · Niki Karachaliou, Sara Pilotto, et al. · Europe PMC (PubMed Central) · 30
KRAS inhibitors, approved
2021 · Rafael Rosell, Andrés Aguilar, et al. · Nature Cancer · 23
Spanish customized adjuvant trial (SCAT) based on BRCA1 mRNA levels
2008 · M. Cobo, B. Massuti, et al. · Journal of Clinical Oncology · 22
Osimertinib and Dihydroartemisinin: A Novel Drug Combination Targeting Head and Neck Squamous Cell Carcinoma
2019 · Imane Chaib, Xueting Cai, et al. · Annals of Translational Medicine · 21
PDF
Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma
2019 · Joan Gibert, Sergi Clavé, et al. · Lung Cancer · 17
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer
2020 · Ilaria Attili, Laura Bonanno, et al. · Translational Lung Cancer Research · 16
PDF
Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer
2019 · Mariacarmela Santarpia, Jessica Menis, et al. · Expert Review of Clinical Pharmacology · 16
Works count: 99
Citation count: 1,718
H-index: 21
I10-index: 34
Year
Topic
Type